(Article begins on next page) The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Wall, Dennis P., and Peter J. Tonellato. 2012. The future ofgenomics in pathology. F1000 Medicine Reports 4
(Article begins on next page) The Harvard community has made this article openly available. Please s...
to manage analyses and publications in a phase III multicenter randomized clinical trial (Article be...
pathway-centric cancer therapies via pharmacogenomic profiling analysis of ERK signalling pathway (A...
emerging genomics and systems biology research lead to systems genomics studies (Article begins on n...
in translational bioinformatics facilitate revealing the landscape of complex disease mechanisms (Ar...
diseases and their risk factors: Findings of a multicenter study (Article begins on next page) The H...
chromatin organization shapes the mutational landscape of cancer (Article begins on next page) The H...
metastasis and tumourigenesis (Article begins on next page) The Harvard community has made this arti...
disease: evidence from the US population (Article begins on next page) The Harvard community has mad...
G1 phase of cycling cells to maintain genomic stability (Article begins on next page) The Harvard co...
prospective study of plasma inflammatory markers and risk of colorectal cancer in men (Article begin...
promoter level mammalian expression atlas (Article begins on next page) The Harvard community has ma...
A direct characterization of human mutation based on microsatellites (Article begins on next page) T...
for genome engineering (Article begins on next page) The Harvard community has made this article ope...
prospective cohort study (Article begins on next page) The Harvard community has made this article o...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
to manage analyses and publications in a phase III multicenter randomized clinical trial (Article be...
pathway-centric cancer therapies via pharmacogenomic profiling analysis of ERK signalling pathway (A...
emerging genomics and systems biology research lead to systems genomics studies (Article begins on n...
in translational bioinformatics facilitate revealing the landscape of complex disease mechanisms (Ar...
diseases and their risk factors: Findings of a multicenter study (Article begins on next page) The H...
chromatin organization shapes the mutational landscape of cancer (Article begins on next page) The H...
metastasis and tumourigenesis (Article begins on next page) The Harvard community has made this arti...
disease: evidence from the US population (Article begins on next page) The Harvard community has mad...
G1 phase of cycling cells to maintain genomic stability (Article begins on next page) The Harvard co...
prospective study of plasma inflammatory markers and risk of colorectal cancer in men (Article begin...
promoter level mammalian expression atlas (Article begins on next page) The Harvard community has ma...
A direct characterization of human mutation based on microsatellites (Article begins on next page) T...
for genome engineering (Article begins on next page) The Harvard community has made this article ope...
prospective cohort study (Article begins on next page) The Harvard community has made this article o...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
to manage analyses and publications in a phase III multicenter randomized clinical trial (Article be...
pathway-centric cancer therapies via pharmacogenomic profiling analysis of ERK signalling pathway (A...